UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051085
Receipt number R000057919
Scientific Title A study on the improvement of hearing ability in patients with unilateral hearing loss (Speech hearing threshold test by Oldenburg sentence test (OLSA))
Date of disclosure of the study information 2023/05/19
Last modified on 2023/05/17 14:00:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on the improvement of hearing ability in patients with unilateral hearing loss
(Speech hearing threshold test by Oldenburg sentence test (OLSA))

Acronym

A study on the improvement of hearing ability in patients with unilateral hearing loss
(Speech hearing threshold test by Oldenburg sentence test (OLSA))

Scientific Title

A study on the improvement of hearing ability in patients with unilateral hearing loss
(Speech hearing threshold test by Oldenburg sentence test (OLSA))

Scientific Title:Acronym

A study on the improvement of hearing ability in patients with unilateral hearing loss
(Speech hearing threshold test by Oldenburg sentence test (OLSA))

Region

Japan


Condition

Condition

unilateral hearing loss

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess binaural hearing with hearing aids in patients with unilateral hearing loss.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

Effects of binaural hearing in noise

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

cross hearing aid

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with unilateral hearing loss

Healthy adult with normal hearing

Key exclusion criteria

1) Hearing-impaired patients with pathological changes in hearing ability
2) Patients who require a disease other than hearing loss that makes speech audiometry (listening to words) impossible
3) In addition, patients who are judged to be inappropriate as research subjects by the research director (co-investigator)

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kazuma
Middle name
Last name Sugahara

Organization

Yamaguchi University Graduate School of Medicine

Division name

Department of Otolaryngology

Zip code

755-8505

Address

1-1-1 Minamikogushi, Ube, Yamaguchi

TEL

0836-22-2281

Email

kazuma@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Kazuma
Middle name
Last name Sugahara

Organization

Yamaguchi University Graduate School of Medicine

Division name

Department of Otolaryngology

Zip code

755-8505

Address

1-1-1 Minamikogushi, Ube, Yamaguchi

TEL

0836-22-2281

Homepage URL


Email

kazuma@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Self research funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamaguchi University Hospital

Address

1-1-1 Minamikogushi, Ube, Yamaguchi

Tel

0836-22-2428

Email

me223@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国際医療福祉大学三田病院,札幌医科大学,国際医療福祉大学病院,慶応義塾大学,浜松医科大学,名古屋大学,信州大学,神戸大学,広島大学,山口大学


Other administrative information

Date of disclosure of the study information

2023 Year 05 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 03 Month 06 Day

Date of IRB

2023 Year 03 Month 22 Day

Anticipated trial start date

2023 Year 03 Month 22 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 05 Month 17 Day

Last modified on

2023 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057919


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name